A Head-to-Head Comparison of AAV9 Biodistribution in Mice: Routes of Administration and Age Dependence
Genes · 2026
DOI: 10.3390/genes17020213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Matthew Rioux und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Genetic Therapy, Gene Transfer Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: internal UT Southwestern Department of Pediatrics funds to SJG.
Abstract (Originalsprache)
Background/Objectives: Adeno-associated virus serotype 9 (AAV9) can cross the blood–brain barrier, making it widely used as a gene delivery vector for central nervous system (CNS) applications. Despite extensive use of AAV9 in translational research, variability in study designs makes cross-comparisons difficult to interpret. We designed a study in mice to generate a resource of AAV9 biodistribution across tissues for commonly used routes of administration and treatment ages.
Methods
Lumbar intrathecal, intracerebroventricular, lumbar intrathecal and intracerebroventricular combination, or intravenous injections of vehicle or AAV9/GFP were performed in C57BL/6J male and female mice on postnatal day 1, 5, 10, or 28. Organs were collected at postnatal day 56 and biodistribution of AAV9/GFP was evaluated by quantifying GFP protein expression and vector genome copy number.
Results
Direct cerebrospinal fluid injections led to higher transgene expression levels in the brain and spinal cord compared to intravenous administration but did not de-target transgene expression in peripheral tissues. Lumbar intrathecal and intracerebroventricular combination injections resulted in expression throughout the CNS but did not substantially increase expression in either the spinal cord or brain beyond the levels obtained with the respective single routes. Treatment age had effects on AAV9 biodistribution regardless of the route of administration, especially in the brain, eye, and liver.
Conclusions
Our results provide the necessary biodistribution data to establish a standardized benchmark for comparison of the current gold standard AAV9 to next generation viral vectors. Additionally, this body of work can provide valuable insights for the design of translational gene therapy studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Matthew Rioux, Steven J Gray
Förderung
- internal UT Southwestern Department of Pediatrics funds to SJG
Zitieren
APA
Rioux, M., Boitnott, A., Paduri, S., Hu, Y., & Gray, S. J. (2026). A Head-to-Head Comparison of AAV9 Biodistribution in Mice: Routes of Administration and Age Dependence. Genes. https://doi.org/10.3390/genes17020213
Vancouver
Rioux M, Boitnott A, Paduri S, Hu Y, Gray SJ. A Head-to-Head Comparison of AAV9 Biodistribution in Mice: Routes of Administration and Age Dependence. Genes. 2026. doi:10.3390/genes17020213
BibTeX
@article{Rioux2026,
author = {Rioux, Matthew and Boitnott, Andrea and Paduri, Satvik and Hu, Yuhui and Gray, Steven J},
title = {A Head-to-Head Comparison of AAV9 Biodistribution in Mice: Routes of Administration and Age Dependence},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17020213}
}
EUVIMED